Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.15.1 extracted from

  • Tang, S.C.; Leung, J.C.; Chan, L.Y.; Eddy, A.A.; Lai, K.N.
    Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy (2008), Kidney Int., 73, 288-299.
    View publication on PubMed

Application

Application Comment Organism
medicine angiotensin-converting enzyme inhibition confers renoprotection in adriamycin nephropathy by reducing intrarenal angiotensin II and augmenting expression of N-acetylseryl-aspartyl-lysyl-proline that together attenuate signaling of mitogen-activated protein kinase and its downstream proinflammatory and fibrinogenic properties Mus musculus

Inhibitors

Inhibitors Comment Organism Structure
captopril angiotensin-converting enzyme inhibition confers renoprotection in adriamycin nephropathy by reducing intrarenal angiotensin II and augmenting expression of N-acetylseryl-aspartyl-lysyl-proline that together attenuate signaling of mitogen-activated protein kinase and its downstream proinflammatory and fibrinogenic properties Mus musculus

Organism

Organism UniProt Comment Textmining
Mus musculus
-
-
-